about
Genetic polymorphism of the human ICOS geneSecretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA depositsMaternal HLA genotyping is not useful for predicting severity of fetal and neonatal alloimmune thrombocytopenia.High-density SNP mapping of the HLA region identifies multiple independent susceptibility loci associated with selective IgA deficiency.Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland.Case report: Severe hemolytic disease of the fetus and newborn due to anti-C+G.The shared CTLA4-ICOS risk locus in celiac disease, IgA deficiency and common variable immunodeficiency.Gliadin antibodies in older population and neurological and psychiatric disorders.Degree of damage to the small bowel and serum antibody titers correlate with clinical presentation of patients with celiac disease.Intestinal alkaline phosphatase at the crossroad of intestinal health and disease - a putative role in type 1 diabetes.Vox Sanguinis International Forum on application of fetal blood grouping: summary.Vox Sanguinis International Forum on application of fetal blood grouping.Evaluation of human leukocyte antigen sensitization in burn patients after treatment with skin allografts and transfusion of blood products.[Where to find a suitable red cell product, if the patient has a rare blood group?].HLA antigen, allele and haplotype frequencies and their use in virtual panel reactive antigen calculations in the Finnish population.Methods for diagnostic HLA typing in disease association and drug hypersensitivity.Association of genetic variation in inducible costimulator gene with outcome of kidney transplantation.Genetic variation in ICOS regulates mRNA levels of ICOS and splicing isoforms of CTLA4.Genetic association of coeliac disease susceptibility to polymorphisms in the ICOS gene on chromosome 2q33Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populationsPersistently positive gliadin antibodies without transglutaminase antibodies in the elderly: Gluten intolerance beyond coeliac diseaseImmunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease.Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac diseaseAntibodies against deamidated gliadin peptides in early-stage celiac diseaseDiagnosing mild enteropathy celiac disease: a randomized, controlled clinical studySerodiagnostic assays for celiac disease based on the open or closed conformation of the autoantigen, transglutaminase 2Gluten-sensitive hypertransaminasemia in celiac disease: an infrequent and often subclinical findingNew RHD variant alleles
P50
Q28208298-68CBB824-970C-4AA1-BF04-5B6974D801A5Q33321946-8E543487-EA46-4588-9943-B7E5E4885BDDQ33436061-8D61500D-6E62-412F-B3A4-8745CC5EF393Q34145740-98145F4A-F368-4CC0-8A76-98C2E60011BAQ38656110-2385343A-6778-4B85-B5ED-18417C5F6386Q38717585-34C9A73B-14A1-4DB5-B1C9-0510350102FBQ42603709-4A286ADB-9FBE-4CE1-8F7B-7BE473FA0173Q43812144-4B671D44-DB6B-4AF1-9C30-FD983E4A6100Q46591471-9498B0F9-CBD6-45A2-ACBC-6FB14B0540BBQ48298448-123C9353-FA6A-4AD0-BB1A-B6278DA88617Q48339570-9329A865-67C0-4C20-B304-23DBABF9A1BFQ48339604-F932F387-F8B7-49E4-BE12-C6D383F16698Q50220282-F2F2CA49-3015-4ACE-9259-6375032E0184Q50278938-E9530192-7093-4083-8E57-56E2BE10F3E0Q50499247-F8DFED75-C37C-4E21-9037-B7142BBFA24CQ50509658-FEFFDCFD-B694-4015-BE35-33B3F98D9681Q50619112-4329B945-3699-479C-8E14-50A962B83582Q50720441-34005E26-A301-4228-A3B2-585FEA7AC29DQ56903521-37AB0880-BB94-4368-BE35-6B3645998627Q56968738-9599BEB8-9F5F-4EC2-87A9-93987AD157F5Q61834994-C756A48F-F608-4B7C-B630-1C2E32CB6F10Q64966964-E1CFD2E9-4EB3-42A4-9896-9A1C80E64D63Q82286254-CDF06975-75A6-4814-9C96-F05B740B5752Q82383808-4F95C66A-4214-4E76-9EB0-C00284E88674Q83102309-1F49F7CB-5D49-44D7-B300-36A111F3E754Q83559355-37F9B427-BA73-4E17-92F2-3DC42BC0E253Q83898810-2EDD35A2-4347-459A-9E03-46AB18462CB5Q85233185-59DCD557-7321-466F-B99A-9FEBF3A970E0
P50
description
researcher
@en
wetenschapper
@nl
name
Haimila K
@nl
Katri Haimila
@en
type
label
Haimila K
@nl
Katri Haimila
@en
altLabel
Haimila K
@en
prefLabel
Haimila K
@nl
Katri Haimila
@en
P106
P31
P496
0000-0001-8904-666X